Erythropoietin receptor is a risk factor for prognosis: A potential biomarker in lung adenocarcinoma
Article in Pathology - Research and Practice (October 2023)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Pathology - Research and Practice (October 2023)
Article in Frontiers in Oncology (March 2022)
Preprint in Research Square (February 2022)